Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in Cambodia
Clinical trial NCT02612545 · COMPLETED
Trial details
- NCT number
- NCT02612545
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-20
- Primary completion
- 2018-10-12
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.